UK Hemp Industry Has Everything It Needs Except the Law

CBD & Hemp
Read More

Rescheduling Stalemate Leaves MSOs Facing a Billion Dollar Tax Reckoning

Markets & Stocks
Read More

Is a Cannabis M&A Tidal Wave on the Way?

Markets & Stocks
Read More

Business Brief: Canify and MG Health Announce Merger

M&A Activity
Read More

Recent Searches

    Popular Searches

    • Glass Pharms
    • medical
    • Medical Cannabis
    • Kanabo Calls in Administrators
    • Article
    • Cannabis Health Symposium
    • antiflamx near me abbotsford bc
    • teaching feeling scene
    • for driving licence test
    • LEADER AM

    Recent Searches

      Popular Searches

      • Glass Pharms
      • medical
      • Medical Cannabis
      • Kanabo Calls in Administrators
      • Article
      • Cannabis Health Symposium
      • antiflamx near me abbotsford bc
      • teaching feeling scene
      • for driving licence test
      • LEADER AM
      Cannabis + Technology, Events, Medical, Videos, Your #1 Podcast on Cannabis News

      Michelle Arbus, Strainprint Technologies

      By
      BofC

      Michelle Arbus heads up research at Strainprint. She joined BofC Live to provide updates about their research project regarding the use of medical cannabis to treat endometriosis.

      BofC

      Other featured articles

      Is the German Cannabis Boom Slowing Down, or Simply Normalising?

      By

      Rescheduling Will Reprice Medical IP, Not Retail Footprints

      By

      The Cannabis Mental Health Evidence Gap: Association vs. Causation

      By

      Patient Protect Launches to Support UK Medical Cannabis Patients Facing Discrimination

      By

      Why Medical Cannabis Clinics Should Be Knocking on Union Doors

      By

      Other featured Cannabis + Technology articles

      How to build compliant and profitable cannabis retail through tech

      By

      Building a compliant supply chain through tech

      By

      Patient-centric tech easing the medical cannabis journey

      By

      Why patient data is critical to developing effective medical cannabis

      By

      How specialization is creating cannabis products of the future

      By

      Share Article

      Related news

      German Cannabis Market Slowdown
      Data & Analysis
      Is the German Cannabis Boom Slowing Down, or Simply Normalising?

      By

      Opinion
      Rescheduling Will Reprice Medical IP, Not Retail Footprints

      By

      Clinical Research
      The Cannabis Mental Health Evidence Gap: Association vs. Causation

      By

      Patient Access
      Patient Protect Launches to Support UK Medical Cannabis Patients Facing Discrimination

      By

      Medical
      Why Medical Cannabis Clinics Should Be Knocking on Union Doors

      By

      Press releases
      The Business of Cannabis Awards Return to London for a Third Year

      By

      Press releases
      Cannabis Europa Launches Reimagined VIP Experience: A New Standard for Senior Decision Makers

      By

      Clinical Research
      Ananda Pharma Cleared to Begin Dosing in NHS-Backed CBD Endometriosis Trial

      By

      Data & Analysis
      Germany’s Post-CanG Import Surge Loses Steam as Q4 Growth Stalls

      By